Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01248182 · ClinicalTrials.gov registry record
Bone to Skin Thickness Study: Obese Versus Normal Population
A clinical trial, sponsored by University of Mississippi Medical Center.
- Terminated
- Registry status
- 21
- Enrollment target
NCT01248182: Clinical Trial study, sponsored by University of Mississippi Medical Center.
NCT01248182 is a clinical trial that was terminated before completion, run by University of Mississippi Medical Center. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01248182 was terminated before completion, sponsored by University of Mississippi Medical Center.
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the bone to skin depth for groups of lean, obese and morbidly obese patients. This information will be potentially helpful with implant design for obese and lean patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-12 |
Why NCT01248182 stopped before completion
NCT01248182 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01248182 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01248182 about?
NCT01248182 is a clinical study titled "Bone to Skin Thickness Study: Obese Versus Normal Population". The purpose of this study is to determine the bone to skin depth for groups of lean, obese and morbidly obese patients. This information will be potentially helpful with implant design for obese and lean patients.
What is the current status of trial NCT01248182?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2010-09. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT01248182?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia